[Otolaryngologist's perspective in childhood adenotonsillar hypertrophy].

The hypertrophy of adenoid and tonsillar is the most common cause of obstructive sleep apnea hypopnea syndrome(OSAHS) in children, which require early diagnosis and standardized treatment to improve behavior, attention and cognitive abilities. Adenotonsillectomy is the primary treatment for pediatric OSAHS with adenotonsillar hypertrophy. Meanwhile, the interest in antiinflammatory agents, such as intranasal corticosteroids and leukotriene antagonists, for childhood OSAHS has also increased.